Published in Inflammopharmacology on April 24, 2011
Induction in gastric mucosal prostaglandin and nitric oxide by Helicobacter pylori is dependent on MAPK/ERK-mediated activation of IKK-β and cPLA2: modulatory effect of ghrelin. Inflammopharmacology (2013) 0.81
Effects of ghrelin on protein expression of antioxidative enzymes and iNOS in the rat liver. Arch Med Sci (2014) 0.79
Role of ghrelin-induced phosphatidylinositol 3-kinase activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori. Inflammopharmacology (2013) 0.79
Modulation of gastric mucosal inflammatory responses to Helicobacter pylori via ghrelin-induced protein kinase Cδ tyrosine phosphorylation. Inflammopharmacology (2014) 0.77
Involvement of p38 MAPK-dependent activator protein (AP-1) activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori by ghrelin. Inflammopharmacology (2012) 0.76
Role of LPS-elicited signaling in triggering gastric mucosal inflammatory responses to H. pylori: modulatory effect of ghrelin. Inflammopharmacology (2017) 0.75
Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature (1999) 17.72
Seven-transmembrane receptors. Nat Rev Mol Cell Biol (2002) 11.50
Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol (1997) 11.36
Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol (2005) 10.65
Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol (2001) 9.82
Assessment and application of the biotin switch technique for examining protein S-nitrosylation under conditions of pharmacologically induced oxidative stress. J Biol Chem (2007) 2.85
Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun (2004) 2.23
Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology (1999) 2.04
S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem (2005) 1.96
Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem (2005) 1.96
Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem (2002) 1.91
S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes (2005) 1.91
Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene (2004) 1.81
Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg (2007) 1.48
S-nitrosylation: NO-related redox signaling to protect against oxidative stress. Antioxid Redox Signal (2006) 1.43
Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery (2007) 1.33
Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology (2008) 1.25
Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab (2004) 1.18
Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase. Proc Natl Acad Sci U S A (2003) 1.18
S-nitrosylation at cysteine 498 of c-Src tyrosine kinase regulates nitric oxide-mediated cell invasion. J Biol Chem (2009) 1.17
Nitric oxide controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J Biol Chem (1999) 1.14
Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol (1997) 1.12
c-Src regulates Akt signaling in response to ghrelin via beta-arrestin signaling-independent and -dependent mechanisms. PLoS One (2009) 1.06
Ghrelin protection against lipopolysaccharide-induced gastric mucosal cell apoptosis involves constitutive nitric oxide synthase-mediated caspase-3 S-nitrosylation. Mediators Inflamm (2010) 0.99
Peroxynitrite activates kinases of the src family and upregulates tyrosine phosphorylation signaling. Free Radic Biol Med (2002) 0.88
Src redox regulation: there is more than meets the eye. Mol Cells (2008) 0.88
Up-regulation of inducible nitric oxide synthase in Helicobacter pylori-associated gastritis may represent an increased risk factor to develop gastric carcinoma of the intestinal type. Int J Med Microbiol (2003) 0.87
Studies of tyrosine phosphorylation and Src family tyrosine kinases in the lens epithelium. Invest Ophthalmol Vis Sci (2005) 0.85
Involvement of constitutive nitric oxide synthase in ghrelin-induced cytosolic phospholipase A(2) activation in gastric mucosal cell protection against ethanol cytotoxicity. Inflammopharmacology (2009) 0.84
Helicobacter pylori Induces Disturbances in Gastric Mucosal Akt Activation through Inducible Nitric Oxide Synthase-Dependent S-Nitrosylation: Effect of Ghrelin. ISRN Gastroenterol (2010) 0.80
Regulatory effects of nitric oxide on Src kinase, FAK, p130Cas, and receptor protein tyrosine phosphatase alpha (PTP-alpha): a role for the cellular redox environment. Antioxid Redox Signal (2010) 0.80
Role of constitutive nitric oxide synthase S-nitrosylation in Helicobacter pylori-induced gastric mucosal cell apoptosis: effect of ghrelin. Inflammopharmacology (2010) 0.77
Ghrelin suppression of Helicobacter pylori-induced S-nitrosylation-dependent Akt inactivation exerts modulatory influence on gastric mucin synthesis. Inflammopharmacology (2011) 0.77
Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun (1987) 3.05
Evidence for weakening of gastric mucus integrity by Campylobacter pylori. Scand J Gastroenterol (1988) 2.03
Lipolytic activity of Campylobacter pylori: effect of colloidal bismuth subcitrate (De-Nol) Am J Gastroenterol (1989) 1.47
Lipid composition of the gastric mucous barrier in the rat. J Biol Chem (1978) 1.28
Salivary mucins in oral mucosal defense. Gen Pharmacol (1996) 1.27
Mechanism of Helicobacter pylori pathogenesis: focus on mucus. J Clin Gastroenterol (1992) 1.19
Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol (1997) 1.12
Transforming growth factor alpha and epidermal growth factor in protection and healing of gastric mucosal injury. Scand J Gastroenterol (1992) 1.09
Campylobacter pylori colonization factor shows specificity for lactosylceramide sulfate and GM3 ganglioside. Biochem Int (1989) 1.08
Isolation of fatty acids covalently bound to the gastric mucus glycoprotein of normal and cystic fibrosis patients. Biochem Biophys Res Commun (1983) 1.06
Isolation and characterization of oligosaccharides from rat colonic mucus glycoprotein. J Biol Chem (1980) 1.06
Role of salivary epidermal growth factor in the maintenance of physicochemical characteristics of oral and gastric mucosal mucus coat. Biochem Biophys Res Commun (1988) 1.04
Structural characterization of neutral oligosaccharides of human H+Leb+ gastric mucin. J Biol Chem (1984) 1.04
Induction of tumor necrosis factor-alpha and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine. Scand J Gastroenterol (1997) 0.99
Gastric mucus and the mucosal barrier. Dig Dis (1987) 0.98
Structures of the neutral oligosaccharides isolated from A-active human gastric mucin. J Biol Chem (1984) 0.97
Glycosulfatase activity of H. pylori toward human gastric mucin: effect of sucralfate. Am J Gastroenterol (1992) 0.95
Covalently linked fatty acids in gastric mucus glycoprotein of cystic fibrosis patients. J Biol Chem (1983) 0.94
Inhibition of Helicobacter pylori colonization by sulfated gastric mucin. Biochem Int (1991) 0.94
Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease. Am J Gastroenterol (1989) 0.94
Cotranslational attachment of fatty acids to nascent peptides in gastric mucus glycoprotein. Biochem Biophys Res Commun (1986) 0.94
The role of covalently bound fatty acids in the degradation of human gastric mucus glycoprotein. Arch Biochem Biophys (1984) 0.93
Characterization of mucus glycoprotein fatty acyltransferase from gastric mucosa. J Biol Chem (1984) 0.90
Hydrogen ion diffusion in dog gastric mucus glycoprotein: effect of associated lipids and covalently bound fatty acids. Biochem Biophys Res Commun (1984) 0.90
Structures of the acidic oligosaccharides isolated from rat sublingual glycoprotein. J Biol Chem (1978) 0.89
Lipid composition of human submandibular gland secretion from light and heavy calculus formers. Arch Oral Biol (1980) 0.89
Lipids associated with rat small-intestinal mucus glycoprotein. Carbohydr Res (1983) 0.89
Role of associated and covalently bound lipids in salivary mucin hydrophobicity: effect of proteolysis and disulfide bridge reduction. Biochem Biophys Res Commun (1988) 0.88
Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun (1991) 0.88
Gastroprotective agents in mucosal defense against Helicobacter pylori. Gen Pharmacol (1994) 0.88
Effect of lipids and proteins on the viscosity of gastric mucus glycoprotein. Biochem Biophys Res Commun (1984) 0.87
Adsorption of human salivary mucins to hydroxyapatite. Arch Oral Biol (1985) 0.87
Gastric mucosal apoptosis induced by ethanol: effect of antiulcer agents. Biochem Mol Biol Int (1997) 0.87
Mucus glycoprotein of human saliva: differences in the associated and covalently bound lipids with caries. Biochim Biophys Acta (1986) 0.87
Activation of apoptotic caspase-3 and nitric oxide synthase-2 in gastric mucosal injury induced by indomethacin. Scand J Gastroenterol (1999) 0.86
Lipolytic activity of Campylobacter pylori: effect of sofalcone. Digestion (1989) 0.86
Carbohydrate heterogeneity of fibronectins. Synovial fluid fibronectin resembles the form secreted by cultured synoviocytes but differs from the plasma form. J Clin Invest (1987) 0.86
Lipid composition of tracheobronchial secretions from normal individuals and patients with cystic fibrosis. Biochim Biophys Acta (1982) 0.86
Role of caspase-3 and nitric oxide synthase-2 in gastric mucosal injury induced by indomethacin: effect of sucralfate. J Physiol Pharmacol (1999) 0.85
Most of the lipid in purulent sputum is bound to mucus glycoprotein. Exp Lung Res (1994) 0.85
Chronic alcohol ingestion enhances tumor necrosis factor-alpha expression and salivary gland apoptosis. Alcohol Clin Exp Res (1997) 0.85
Studies on changes in lipid profiles of the rat gastric mucosa with stress ulcers. Clin Chim Acta (1975) 0.85
Lysolecithin affects the viscosity, permeability, and peptic susceptibility of gastric mucin. Scand J Gastroenterol (1986) 0.85
Purification of protein fatty acyltransferase and determination of its distribution and topology. J Biol Chem (1990) 0.85
Differential expression of salivary mucin bacterial aggregating activity with caries status. Int J Biochem (1993) 0.85
Involvement of constitutive nitric oxide synthase in ghrelin-induced cytosolic phospholipase A(2) activation in gastric mucosal cell protection against ethanol cytotoxicity. Inflammopharmacology (2009) 0.84
Role of ERK and p38 mitogen-activated protein kinase cascades in gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. IUBMB Life (2001) 0.84
Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases. Am J Gastroenterol (1992) 0.84
Forssman glycolipid variants of dog gastric mucosa. Structure of a branched ceramide octasaccharide. Eur J Biochem (1978) 0.83
The role of surface and intracellular mucus in gastric mucosal protection against hydrogen ion. Compositional differences. Scand J Gastroenterol (1985) 0.83
Effect of Helicobacter pylori lipopolysaccharide on the synthesis of sulfated gastric mucin. Biochem Int (1992) 0.83
Alterations in buccal mucosal endothelin-1 and nitric oxide synthase with chronic alcohol ingestion. Biochem Mol Biol Int (1998) 0.83
Association of lipids with proteins and glycoproteins in human saliva. J Dent Res (1983) 0.83
Lipid composition of human parotid saliva from light and heavy dental calculus-formers. Arch Oral Biol (1981) 0.83
Glycosulfatase activity of Helicobacter pylori toward gastric mucin. Biochem Biophys Res Commun (1992) 0.83
Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone. Biochem Int (1992) 0.83
Inhibition of Helicobacter pylori urease activity by ebrotidine. Biochem Mol Biol Int (1995) 0.83
Role of mucus in gastric mucosal protection. J Physiol Pharmacol (1991) 0.82
Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine. J Physiol Pharmacol (1995) 0.82
Tyrosylprotein sulfotransferase in rat submandibular salivary glands. Int J Biochem (1992) 0.82
Association of salivary bacterial aggregating activity with sulfomucin. Biochem Mol Biol Int (1994) 0.82
Effect of acetylsalicylic acid on gastric mucin viscosity, permeability to hydrogen ion, and susceptibility to pepsin. Biochem Pharmacol (1986) 0.82
In vitro acylation of rat gastric mucus glycoprotein with [3H]palmitic acid. J Biol Chem (1984) 0.82
The glycosphingolipids of rat sublingual and submaxillary glands. Biochim Biophys Acta (1976) 0.82
Tooth surface-pellicle lipids and their role in the protection of dental enamel against lactic-acid diffusion in man. Arch Oral Biol (1986) 0.82
Water-soluble glycosphingolipids of dog gastric mucosa. Characterization of a branched ceramide heptasaccharide. Eur J Biochem (1977) 0.82
Transglutaminase activity in human colorectal carcinomas of differing metastatic potential. Cancer Lett (1991) 0.82
Salivary lipids in health and disease. Prog Lipid Res (1985) 0.82
Induction in gastric mucosal prostaglandin and nitric oxide by Helicobacter pylori is dependent on MAPK/ERK-mediated activation of IKK-β and cPLA2: modulatory effect of ghrelin. Inflammopharmacology (2013) 0.81
Nitecapone effect on the synthesis and secretion of gastric sulfomucin. Gen Pharmacol (1993) 0.81
Evidence for proteolytic disruption of gastric mucus coat by Campylobacter pylori. S Afr Med J (1988) 0.81
Branched blood group A-active fucolipids of hog gastric mucosa. Biochim Biophys Acta (1977) 0.81
Leptin protection of salivary gland acinar cells against ethanol cytotoxicity involves Src kinase-mediated parallel activation of prostaglandin and constitutive nitric oxide synthase pathways. Inflammopharmacology (2008) 0.81
Delay in oral mucosal ulcer healing by aspirin is linked to the disturbances in p38 mitogen-activated protein kinase activation. J Physiol Pharmacol (2001) 0.81
Lipid composition of human parotid and submandibular saliva from caries-resistant and caries-susceptible adults. Arch Oral Biol (1982) 0.81
Suppression of Helicobacter pylori protease activity towards growth factors by sulglycotide. J Physiol Pharmacol (1997) 0.81
ABH-blood-group antigens and glycolipids of human saliva. Eur J Biochem (1978) 0.81
In vitro inhibition of peptic degradation of porcine gastric mucus glycoprotein by sucralfate. Scand J Gastroenterol (1985) 0.81
Lipid composition of submandibular saliva from normal and cystic fibrosis individuals. J Dent Res (1982) 0.81
Physico-chemical characteristics of mucus glycoproteins and lipids of the human oral mucosal mucus coat in relation to caries susceptibility. Arch Oral Biol (1989) 0.81
Inhibition of tyrosylprotein sulfotransferase by sphingosine and its reversal by acidic phospholipids. Biochemistry (1993) 0.81
Gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide: down-regulation of nitric oxide synthase-2 and caspase-3 by sulglycotide. Biochem Biophys Res Commun (1999) 0.81
Role of endothelin-1 and constitutive nitric oxide synthase in gastric mucosal resistance to indomethacin injury: effect of antiulcer agents. Scand J Gastroenterol (1999) 0.80
Role of epidermal growth factor receptor transactivation in the activation of cytosolic phospholipase A(2) in leptin protection of salivary gland acinar cells against ethanol cytotoxicity. J Physiol Pharmacol (2009) 0.80
Fatty acid acylation of salivary mucin in rat submandibular glands. Arch Biochem Biophys (1985) 0.80
Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro. Am J Gastroenterol (1990) 0.80
Induction of caspase-3 and nitric oxide synthase-2 during gastric mucosal inflammatory reaction to Helicobacter pylori lipopolysaccharide. Biochem Mol Biol Int (1998) 0.80
Helicobacter pylori lipopolysaccharide induces gastric epithelial cells apoptosis. Biochem Mol Biol Int (1996) 0.80
Leptin modulates the detrimental effect of Porphyromonas gingivalis lipopolysaccharide-induced cytosolic phospholipase A2 activation on salivary mucin synthesis via ERK-signal transduction. Inflammopharmacology (2006) 0.80
Enhancement of the lipid content and physical properties of gastric mucus by geranylgeranylacetone. Biochem Pharmacol (1987) 0.80
Constitutive nitric oxide synthase-mediated caspase-3 S-nitrosylation in ghrelin protection against Porphyromonas gingivalis-induced salivary gland acinar cell apoptosis. Inflammopharmacology (2010) 0.80
Salivary and plasma insulin levels in man. Biochem Mol Biol Int (1993) 0.80
Lipid composition of human labial salivary gland secretions. Arch Oral Biol (1983) 0.80
Up-regulation of endothelin-converting enzyme-1 in gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun (2000) 0.80
Effect of acetylsalicylic acid on the constituents of the gastric mucosal barrier. Scand J Gastroenterol (1984) 0.80
Characterization of the Forssman-active oligosaccharides from dog gastric mucus glycoprotein isolated with the use of a monoclonal antibody. J Biol Chem (1982) 0.79
Impairment by ethanol of prostaglandin production in rat salivary glands. Arch Oral Biol (1991) 0.79
The glycoprotein nature of Forssman antigen in dog gastric mucus. FEBS Lett (1981) 0.79
Effect of lipids on the lactic acid retardation capacity of tooth enamel and cementum pellicles formed in vitro from saliva of caries-resistant and caries-susceptible human adults. Arch Oral Biol (1990) 0.79
Identification of buccal mucosal mucin receptor. Biochem Mol Biol Int (1993) 0.79